United States · FDA National Drug Code directory
Cetirizine HCl
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 30142-995_42b647c4-2c0a-dece-e063-6294a90a3cb5
- Product NDC
- 30142-995
- Form
- CAPSULE
- Composition / generic term
- Cetirizine HCl
- Labeler
- KROGER COMPANY
- Marketing category
- NDA
- Marketing start / end (source format)
- 20190603
- Source listing expiry
- 20261231
Source-listed ingredients
- CETIRIZINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, PLASTIC in 1 CARTON (30142-995-25) / 25 CAPSULE in 1 BOTTLE, PLASTIC · 30142-995-25
- 1 BOTTLE, PLASTIC in 1 CARTON (30142-995-40) / 40 CAPSULE in 1 BOTTLE, PLASTIC · 30142-995-40
- 1 BOTTLE, PLASTIC in 1 CARTON (30142-995-50) / 50 CAPSULE in 1 BOTTLE, PLASTIC · 30142-995-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →